Cardiac Marker Testing Market Projected to Reach USD 11,771.28 Million by 2034, Growing at a 9.4% CAGR

The cardiac marker testing market is expected to gain market growth during the forecast period of 2025-2034. Polaris Market Research analyzes the market to account for USD 11,771.28 million by 2034 and is expected to register a CAGR of 9.4% in the above-mentioned forecast period. The market was valued at USD 4,804.49 million in 2024.

Market Analysis:
Cardiac marker tests measure the levels of specific substances in the blood, such as enzymes, hormones, or proteins, to assess heart function. When the heart undergoes significant stress, often due to a lack of sufficient oxygen, cardiac markers are released into the bloodstream, a process that can indicate a heart attack. However, elevated levels of these markers can also occur due to other conditions, such as kidney disease. These groups of markers are frequently used to determine the extent of a heart attack and the severity of heart damage in real-time.

Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/cardiac-marker-testing-market/request-for-sample

Driving Factors:
Growing Cases of Cardiovascular Illnesses: The growing cases of cardiovascular illnesses are pushing the market growth as it notably escalates the demand for premature and precise diagnosis. Cardiovascular illnesses involving heart attacks, strokes, and heart failure are the spearheading factors of deaths globally, demanding the usage of cardiac biomarkers for punctual detection and handling, driving up the cardiac marker testing market demand.

Progression in Point-of-Care Testing Gadgets: Technological progressions have caused the advancement of progressive point-of-care testing (POCT) devices improving the reach and productivity of cardiac marker testing. Modern POCT gadgets provide speedy and precise outcomes, easing instant clinical resolution.

Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/cardiac-marker-testing-market/request-for-discount-pricing

Competitive Landscape:
Leading players in the market are focusing on strategic initiatives such as product launches, partnerships, and acquisitions to strengthen their market position. Key companies are mentioned below:
• Abbott Laboratories
• Becton, Dickinson and Company
• bioMérieux SA
• CardioGenics Holdings Inc.
• Danaher Corporation
• DiaSorin S.p.A.
• F. Hoffmann-La Roche Ltd.
• LSI Medience Corporation
• Ortho Clinical Diagnostics
• PerkinElmer Inc.
• Quidel Corporation
• Randox Laboratories Ltd.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

Developments in the Cardiac Marker Testing Industry:
• January 2025: Roche's whole slide imaging system, Roche Digital Pathology Dx, received FDA approval for the VENTANA DP 600 slide scanner.

• October 2023: Mindray, a global provider of medical devices and solutions, launched two new cardiac biomarkers worldwide: high-sensitivity troponin I (hs-cTnI) and NT-proBNP.

Market Segmentation:
The cardiac marker testing segmentation is based on product, biomarker type, end user, and region.

Based on product, the reagents & kits segment held the largest market share in 2024 due to extensive usage in laboratory settings providing high susceptibility and precision in locating cardiac biomarkers.

Based on biomarker type, the troponin I & T segment dominated the market in 2024 due to their preciseness and sensitivity for myocardial injury.

Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/cardiac-marker-testing-market

By Product Outlook (Revenue - USD Million, 2020-2034)
• Reagents & Kits
• Instruments

By Biomarker Type Outlook (Revenue - USD Million, 2020-2034)
• Troponin I & T
• Creatine Kinase-MB (CK-MB)
• Natriuretic Peptide
• Myoglobin
• High Sensitivity C-Reactive Protein
• Other Cardiac Biomarkers

By End User Outlook (Revenue - USD Million, 2020-2034)
• Laboratory Testing Facilities
• Point-Of-Care Testing Facilities
• Academic Institutions

Buy Now:
https://www.polarismarketresearch.com/buy/2282/0

Geographical Insights:
• North America
o US
o Canada

• Europe
o Germany
o France
o UK
o Italy
o Spain
o Netherlands
o Russia
o Rest of Europe

• Asia Pacific
o China
o Japan
o India
o Malaysia
o South Korea
o Indonesia
o Australia
o Vietnam
o Rest of Asia Pacific

• Middle East & Africa
o Saudi Arabia
o UAE
o Israel
o South Africa
o Rest of Middle East & Africa

• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America

Browse More Research Reports:
Chronic Obstructive Pulmonary Disease Market:
https://www.polarismarketresearch.com/industry-analysis/global-chronic-obstructive-pulmonary-disease-market

Cell Lysis & Disruption Market:
https://www.polarismarketresearch.com/industry-analysis/cell-lysis-disruption-market

Immunoassay Market:
https://www.polarismarketresearch.com/industry-analysis/immunoassay-market

Rare Disease Genetic Testing Market:
https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market

Latent TB Testing Market:
https://www.polarismarketresearch.com/industry-analysis/latent-tb-testing-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.